Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 207 entries
Sorted by: Best Match Show Resources per page
Embracing complexity with systems thinking in general practitioners' clinical reasoning helps handling uncertainty.

Journal of evaluation in clinical practice

Stolper E, Van Royen P, Jack E, Uleman J, Olde Rikkert M.
PMID: 33592677
J Eval Clin Pract. 2021 Oct;27(5):1175-1181. doi: 10.1111/jep.13549. Epub 2021 Feb 16.

Clinical reasoning in general practice is increasingly challenging because of the rise in the number of patients with multimorbidity. This creates uncertainty because of unpredictable interactions between the symptoms from multiple medical problems and the patient's personality, psychosocial context...

Cite
Stolper E, Van Royen P, Jack E, et al. Embracing complexity with systems thinking in general practitioners' clinical reasoning helps handling uncertainty. J Eval Clin Pract. 2021;27(5):1175-1181doi: 10.1111/jep.13549.
Stolper, E., Van Royen, P., Jack, E., Uleman, J., & Olde Rikkert, M. (2021). Embracing complexity with systems thinking in general practitioners' clinical reasoning helps handling uncertainty. Journal of evaluation in clinical practice, 27(5), 1175-1181. https://doi.org/10.1111/jep.13549
Stolper, Erik, et al. "Embracing complexity with systems thinking in general practitioners' clinical reasoning helps handling uncertainty." Journal of evaluation in clinical practice vol. 27,5 (2021): 1175-1181. doi: https://doi.org/10.1111/jep.13549
Stolper E, Van Royen P, Jack E, Uleman J, Olde Rikkert M. Embracing complexity with systems thinking in general practitioners' clinical reasoning helps handling uncertainty. J Eval Clin Pract. 2021 Oct;27(5):1175-1181. doi: 10.1111/jep.13549. Epub 2021 Feb 16. PMID: 33592677; PMCID: PMC8518614.
Copy Download .nbib Format: NLM
Infarct-related chronic total coronary occlusion and the risk of ventricular tachyarrhythmic events in out-of-hospital cardiac arrest survivors.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van der Graaf M, Jewbali LSD, Lemkes JS, Spoormans EM, van der Ent M, Meuwissen M, Blans MJ, van der Harst P, Henriques JP, Beishuizen A, Camaro C, Bleeker GB, van Royen N, Yap SC.
PMID: 34046780
Neth Heart J. 2021 Oct;29(10):500-505. doi: 10.1007/s12471-021-01578-3. Epub 2021 May 27.

INTRODUCTION: Chronic total coronary occlusion (CTO) has been identified as a risk factor for ventricular arrhythmias, especially a CTO in an infarct-related artery (IRA). This study aimed to evaluate the effect of an IRA-CTO on the occurrence of ventricular...

Cite
van der Graaf M, Jewbali LSD, Lemkes JS, et al. Infarct-related chronic total coronary occlusion and the risk of ventricular tachyarrhythmic events in out-of-hospital cardiac arrest survivors. Neth Heart J. 2021;29(10):500-505doi: 10.1007/s12471-021-01578-3.
van der Graaf, M., Jewbali, L. S. D., Lemkes, J. S., Spoormans, E. M., van der Ent, M., Meuwissen, M., Blans, M. J., van der Harst, P., Henriques, J. P., Beishuizen, A., Camaro, C., Bleeker, G. B., van Royen, N., & Yap, S. C. (2021). Infarct-related chronic total coronary occlusion and the risk of ventricular tachyarrhythmic events in out-of-hospital cardiac arrest survivors. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 29(10), 500-505. https://doi.org/10.1007/s12471-021-01578-3
van der Graaf, M, et al. "Infarct-related chronic total coronary occlusion and the risk of ventricular tachyarrhythmic events in out-of-hospital cardiac arrest survivors." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 29,10 (2021): 500-505. doi: https://doi.org/10.1007/s12471-021-01578-3
van der Graaf M, Jewbali LSD, Lemkes JS, Spoormans EM, van der Ent M, Meuwissen M, Blans MJ, van der Harst P, Henriques JP, Beishuizen A, Camaro C, Bleeker GB, van Royen N, Yap SC. Infarct-related chronic total coronary occlusion and the risk of ventricular tachyarrhythmic events in out-of-hospital cardiac arrest survivors. Neth Heart J. 2021 Oct;29(10):500-505. doi: 10.1007/s12471-021-01578-3. Epub 2021 May 27. PMID: 34046780; PMCID: PMC8455757.
Copy Download .nbib Format: NLM
From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.

Journal of personalized medicine

Decaesteker B, Durinck K, Van Roy N, De Wilde B, Van Neste C, Van Haver S, Roberts S, De Preter K, Vermeirssen V, Speleman F.
PMID: 34945759
J Pers Med. 2021 Dec 03;11(12). doi: 10.3390/jpm11121286.

Neuroblastoma is a pediatric tumor arising from the sympatho-adrenal lineage and a worldwide leading cause of childhood cancer-related deaths. About half of high-risk patients die from the disease while survivors suffer from multiple therapy-related side-effects. While neuroblastomas present with...

Cite
Decaesteker B, Durinck K, Van Roy N, et al. From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. J Pers Med. 2021;11(12)doi: 10.3390/jpm11121286.
Decaesteker, B., Durinck, K., Van Roy, N., De Wilde, B., Van Neste, C., Van Haver, S., Roberts, S., De Preter, K., Vermeirssen, V., & Speleman, F. (2021). From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. Journal of personalized medicine, 11(12), . https://doi.org/10.3390/jpm11121286
Decaesteker, Bieke, et al. "From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma." Journal of personalized medicine vol. 11,12 (2021). doi: https://doi.org/10.3390/jpm11121286
Decaesteker B, Durinck K, Van Roy N, De Wilde B, Van Neste C, Van Haver S, Roberts S, De Preter K, Vermeirssen V, Speleman F. From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. J Pers Med. 2021 Dec 03;11(12). doi: 10.3390/jpm11121286. PMID: 34945759; PMCID: PMC8707517.
Copy Download .nbib Format: NLM
Contribution of three-dimensional images in the planning of cementoblastoma resection.

BJR case reports

Van Hoe S, Shaheen E, de Faria Vasconcelos K, Schoenaers J, Politis C, Jacobs R.
PMID: 34131494
BJR Case Rep. 2021 Jan 08;7(3):20200156. doi: 10.1259/bjrcr.20200156. eCollection 2021 May 01.

Cementoblastomas are rare benign tumours that represent less than 1% of all odontogenic tumours. Complete resection is mandatory to avoid recurrence. This case report describes the contribution of three-dimensional imaging and three-dimensional printing in the pre-operative surgical planning of...

Cite
Van Hoe S, Shaheen E, de Faria Vasconcelos K, et al. Contribution of three-dimensional images in the planning of cementoblastoma resection. BJR Case Rep. 2021;7(3):20200156doi: 10.1259/bjrcr.20200156.
Van Hoe, S., Shaheen, E., de Faria Vasconcelos, K., Schoenaers, J., Politis, C., & Jacobs, R. (2021). Contribution of three-dimensional images in the planning of cementoblastoma resection. BJR case reports, 7(3), 20200156. https://doi.org/10.1259/bjrcr.20200156
Van Hoe, Stefaan, et al. "Contribution of three-dimensional images in the planning of cementoblastoma resection." BJR case reports vol. 7,3 (2021): 20200156. doi: https://doi.org/10.1259/bjrcr.20200156
Van Hoe S, Shaheen E, de Faria Vasconcelos K, Schoenaers J, Politis C, Jacobs R. Contribution of three-dimensional images in the planning of cementoblastoma resection. BJR Case Rep. 2021 Jan 08;7(3):20200156. doi: 10.1259/bjrcr.20200156. eCollection 2021 May 01. PMID: 34131494; PMCID: PMC8171136.
Copy Download .nbib Format: NLM
Association of unbalanced translocation der(1;7) with germline GATA2 mutations.

Blood

Kozyra EJ, Göhring G, Hickstein DD, Calvo KR, DiNardo CD, Dworzak M, de Haas V, Starý J, Hasle H, Shimamura A, Fleming MD, Inaba H, Lewis S, Hsu AP, Holland SM, Arnold DE, Mecucci C, Keel SB, Bertuch AA, Tawana K, Barzilai S, Hirabayashi S, Onozawa M, Lei S, Alaiz H, Andrikovics H, Betts D, Beverloo BH, Buechner J, Čermák M, Cervera J, Haus O, Jahnukainen K, Manola KN, Nebral K, Pasquali F, Tchinda J, Turkiewicz D, Van Roy N, Zemanova Z, Pastor VB, Strahm B, Noellke P, Niemeyer CM, Schlegelberger B, Yoshimi A, Wlodarski MW.
PMID: 34469508
Blood. 2021 Dec 09;138(23):2441-2445. doi: 10.1182/blood.2021012781.

No abstract available.

Cite
Kozyra EJ, Göhring G, Hickstein DD, et al. Association of unbalanced translocation der(1;7) with germline GATA2 mutations. Blood. 2021;138(23):2441-2445doi: 10.1182/blood.2021012781.
Kozyra, E. J., Göhring, G., Hickstein, D. D., Calvo, K. R., DiNardo, C. D., Dworzak, M., de Haas, V., Starý, J., Hasle, H., Shimamura, A., Fleming, M. D., Inaba, H., Lewis, S., Hsu, A. P., Holland, S. M., Arnold, D. E., Mecucci, C., Keel, S. B., Bertuch, A. A., Tawana, K., Barzilai, S., Hirabayashi, S., Onozawa, M., Lei, S., Alaiz, H., Andrikovics, H., Betts, D., Beverloo, B. H., Buechner, J., Čermák, M., Cervera, J., Haus, O., Jahnukainen, K., Manola, K. N., Nebral, K., Pasquali, F., Tchinda, J., Turkiewicz, D., Van Roy, N., Zemanova, Z., Pastor, V. B., Strahm, B., Noellke, P., Niemeyer, C. M., Schlegelberger, B., Yoshimi, A., & Wlodarski, M. W. (2021). Association of unbalanced translocation der(1;7) with germline GATA2 mutations. Blood, 138(23), 2441-2445. https://doi.org/10.1182/blood.2021012781
Kozyra, Emilia J, et al. "Association of unbalanced translocation der(1;7) with germline GATA2 mutations." Blood vol. 138,23 (2021): 2441-2445. doi: https://doi.org/10.1182/blood.2021012781
Kozyra EJ, Göhring G, Hickstein DD, Calvo KR, DiNardo CD, Dworzak M, de Haas V, Starý J, Hasle H, Shimamura A, Fleming MD, Inaba H, Lewis S, Hsu AP, Holland SM, Arnold DE, Mecucci C, Keel SB, Bertuch AA, Tawana K, Barzilai S, Hirabayashi S, Onozawa M, Lei S, Alaiz H, Andrikovics H, Betts D, Beverloo BH, Buechner J, Čermák M, Cervera J, Haus O, Jahnukainen K, Manola KN, Nebral K, Pasquali F, Tchinda J, Turkiewicz D, Van Roy N, Zemanova Z, Pastor VB, Strahm B, Noellke P, Niemeyer CM, Schlegelberger B, Yoshimi A, Wlodarski MW. Association of unbalanced translocation der(1;7) with germline GATA2 mutations. Blood. 2021 Dec 09;138(23):2441-2445. doi: 10.1182/blood.2021012781. PMID: 34469508; PMCID: PMC8662074.
Copy Download .nbib Format: NLM
The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma.

The Journal of pathology

Ruh M, Stemmler MP, Frisch I, Fuchs K, van Roey R, Kleemann J, Roas M, Schuhwerk H, Eccles RL, Agaimy A, Baumhoer D, Berx G, Müller F, Brabletz T, Brabletz S.
PMID: 33675037
J Pathol. 2021 Jun;254(2):199-211. doi: 10.1002/path.5659. Epub 2021 May 06.

Osteosarcoma is an often-fatal mesenchyme-derived malignancy in children and young adults. Overexpression of EMT-transcription factors (EMT-TFs) has been associated with poor clinical outcome. Here, we demonstrated that the EMT-TF ZEB1 is able to block osteoblastic differentiation in normal bone...

Cite
Ruh M, Stemmler MP, Frisch I, et al. The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. J Pathol. 2021;254(2):199-211doi: 10.1002/path.5659.
Ruh, M., Stemmler, M. P., Frisch, I., Fuchs, K., van Roey, R., Kleemann, J., Roas, M., Schuhwerk, H., Eccles, R. L., Agaimy, A., Baumhoer, D., Berx, G., Müller, F., Brabletz, T., & Brabletz, S. (2021). The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. The Journal of pathology, 254(2), 199-211. https://doi.org/10.1002/path.5659
Ruh, Manuel, et al. "The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma." The Journal of pathology vol. 254,2 (2021): 199-211. doi: https://doi.org/10.1002/path.5659
Ruh M, Stemmler MP, Frisch I, Fuchs K, van Roey R, Kleemann J, Roas M, Schuhwerk H, Eccles RL, Agaimy A, Baumhoer D, Berx G, Müller F, Brabletz T, Brabletz S. The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. J Pathol. 2021 Jun;254(2):199-211. doi: 10.1002/path.5659. Epub 2021 May 06. PMID: 33675037.
Copy Download .nbib Format: NLM
Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial.

JAMA cardiology

Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen MM, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak RR, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, Spoormans EM, van de Ven PM, Oudemans-van Straaten HM, van Royen N.
PMID: 32876654
JAMA Cardiol. 2020 Dec 01;5(12):1358-1365. doi: 10.1001/jamacardio.2020.3670.

IMPORTANCE: Ischemic heart disease is a common cause of cardiac arrest. However, randomized data on long-term clinical outcomes of immediate coronary angiography and percutaneous coronary intervention (PCI) in patients successfully resuscitated from cardiac arrest in the absence of ST...

Cite
Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial. JAMA Cardiol. 2020;5(12):1358-1365doi: 10.1001/jamacardio.2020.3670.
Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., Meuwissen, M. M., Rijpstra, T. A., Bosker, H. A., Blans, M. J., Bleeker, G. B., Baak, R. R., Vlachojannis, G. J., Eikemans, B. J. W., van der Harst, P., van der Horst, I. C. C., Voskuil, M., van der Heijden, J. J., Beishuizen, A., Stoel, M., Camaro, C., van der Hoeven, H., Henriques, J. P., Vlaar, A. P. J., Vink, M. A., van den Bogaard, B., Heestermans, T. A. C. M., de Ruijter, W., Delnoij, T. S. R., Crijns, H. J. G. M., Jessurun, G. A. J., Oemrawsingh, P. V., Gosselink, M. T. M., Plomp, K., Magro, M., Elbers, P. W. G., Spoormans, E. M., van de Ven, P. M., Oudemans-van Straaten, H. M., & van Royen, N. (2020). Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial. JAMA cardiology, 5(12), 1358-1365. https://doi.org/10.1001/jamacardio.2020.3670
Lemkes, Jorrit S, et al. "Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial." JAMA cardiology vol. 5,12 (2020): 1358-1365. doi: https://doi.org/10.1001/jamacardio.2020.3670
Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen MM, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak RR, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, Spoormans EM, van de Ven PM, Oudemans-van Straaten HM, van Royen N. Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial. JAMA Cardiol. 2020 Dec 01;5(12):1358-1365. doi: 10.1001/jamacardio.2020.3670. PMID: 32876654; PMCID: PMC7489423.
Copy Download .nbib Format: NLM
Waveguide-based absorption measurement system for visible wavelength applications.

Biomedical optics express

Neutens P, Jansen R, Woronoff G, Rutowska M, Hosseini N, Buja F, Humbert A, Colle F, Stakenborg T, Van Roy W.
PMID: 33996215
Biomed Opt Express. 2021 Mar 15;12(4):2041-2053. doi: 10.1364/BOE.418264. eCollection 2021 Apr 01.

We present a miniaturized waveguide-based absorption measurement system operating at a wavelength of 635 nm, based on a silicon nitride integrated photonic platform, suitable for lab-on-chip applications. We experimentally demonstrate a high correlation between the bulk dye concentration and...

Cite
Neutens P, Jansen R, Woronoff G, et al. Waveguide-based absorption measurement system for visible wavelength applications. Biomed Opt Express. 2021;12(4):2041-2053doi: 10.1364/BOE.418264.
Neutens, P., Jansen, R., Woronoff, G., Rutowska, M., Hosseini, N., Buja, F., Humbert, A., Colle, F., Stakenborg, T., & Van Roy, W. (2021). Waveguide-based absorption measurement system for visible wavelength applications. Biomedical optics express, 12(4), 2041-2053. https://doi.org/10.1364/BOE.418264
Neutens, P, et al. "Waveguide-based absorption measurement system for visible wavelength applications." Biomedical optics express vol. 12,4 (2021): 2041-2053. doi: https://doi.org/10.1364/BOE.418264
Neutens P, Jansen R, Woronoff G, Rutowska M, Hosseini N, Buja F, Humbert A, Colle F, Stakenborg T, Van Roy W. Waveguide-based absorption measurement system for visible wavelength applications. Biomed Opt Express. 2021 Mar 15;12(4):2041-2053. doi: 10.1364/BOE.418264. eCollection 2021 Apr 01. PMID: 33996215; PMCID: PMC8086454.
Copy Download .nbib Format: NLM
From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.

Journal of personalized medicine

Decaesteker B, Durinck K, Van Roy N, De Wilde B, Van Neste C, Van Haver S, Roberts S, De Preter K, Vermeirssen V, Speleman F.
PMID: 34945759
J Pers Med. 2021 Dec 03;11(12). doi: 10.3390/jpm11121286.

Neuroblastoma is a pediatric tumor arising from the sympatho-adrenal lineage and a worldwide leading cause of childhood cancer-related deaths. About half of high-risk patients die from the disease while survivors suffer from multiple therapy-related side-effects. While neuroblastomas present with...

Cite
Decaesteker B, Durinck K, Van Roy N, et al. From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. J Pers Med. 2021;11(12)doi: 10.3390/jpm11121286.
Decaesteker, B., Durinck, K., Van Roy, N., De Wilde, B., Van Neste, C., Van Haver, S., Roberts, S., De Preter, K., Vermeirssen, V., & Speleman, F. (2021). From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. Journal of personalized medicine, 11(12), . https://doi.org/10.3390/jpm11121286
Decaesteker, Bieke, et al. "From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma." Journal of personalized medicine vol. 11,12 (2021). doi: https://doi.org/10.3390/jpm11121286
Decaesteker B, Durinck K, Van Roy N, De Wilde B, Van Neste C, Van Haver S, Roberts S, De Preter K, Vermeirssen V, Speleman F. From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma. J Pers Med. 2021 Dec 03;11(12). doi: 10.3390/jpm11121286. PMID: 34945759.
Copy Download .nbib Format: NLM
The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma.

The Journal of pathology

Ruh M, Stemmler MP, Frisch I, Fuchs K, van Roey R, Kleemann J, Roas M, Schuhwerk H, Eccles RL, Agaimy A, Baumhoer D, Berx G, Müller F, Brabletz T, Brabletz S.
PMID: 33675037
J Pathol. 2021 Jun;254(2):199-211. doi: 10.1002/path.5659. Epub 2021 May 06.

Osteosarcoma is an often-fatal mesenchyme-derived malignancy in children and young adults. Overexpression of EMT-transcription factors (EMT-TFs) has been associated with poor clinical outcome. Here, we demonstrated that the EMT-TF ZEB1 is able to block osteoblastic differentiation in normal bone...

Cite
Ruh M, Stemmler MP, Frisch I, et al. The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. J Pathol. 2021;254(2):199-211doi: 10.1002/path.5659.
Ruh, M., Stemmler, M. P., Frisch, I., Fuchs, K., van Roey, R., Kleemann, J., Roas, M., Schuhwerk, H., Eccles, R. L., Agaimy, A., Baumhoer, D., Berx, G., Müller, F., Brabletz, T., & Brabletz, S. (2021). The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. The Journal of pathology, 254(2), 199-211. https://doi.org/10.1002/path.5659
Ruh, Manuel, et al. "The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma." The Journal of pathology vol. 254,2 (2021): 199-211. doi: https://doi.org/10.1002/path.5659
Ruh M, Stemmler MP, Frisch I, Fuchs K, van Roey R, Kleemann J, Roas M, Schuhwerk H, Eccles RL, Agaimy A, Baumhoer D, Berx G, Müller F, Brabletz T, Brabletz S. The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. J Pathol. 2021 Jun;254(2):199-211. doi: 10.1002/path.5659. Epub 2021 May 06. PMID: 33675037.
Copy Download .nbib Format: NLM
Outcome Indicators on Interprofessional Collaboration Interventions for Elderly.

International journal of integrated care

Tsakitzidis G, Timmermans O, Callewaert N, Verhoeven V, Lopez-Hartmann M, Truijen S, Meulemans H, Van Royen P.
PMID: 27616961
Int J Integr Care. 2016 May 16;16(2):5. doi: 10.5334/ijic.2017.

BACKGROUND: Geriatric care increasingly needs more multidisciplinary health care services to deliver the necessary complex and continuous care. The aim of this study is to summarize indicators of effective interprofessional outcomes for this population.METHOD: A systematic review is performed...

Cite
Tsakitzidis G, Timmermans O, Callewaert N, et al. Outcome Indicators on Interprofessional Collaboration Interventions for Elderly. Int J Integr Care. 2016;16(2):5doi: 10.5334/ijic.2017.
Tsakitzidis, G., Timmermans, O., Callewaert, N., Verhoeven, V., Lopez-Hartmann, M., Truijen, S., Meulemans, H., & Van Royen, P. (2016). Outcome Indicators on Interprofessional Collaboration Interventions for Elderly. International journal of integrated care, 16(2), 5. https://doi.org/10.5334/ijic.2017
Tsakitzidis, Giannoula, et al. "Outcome Indicators on Interprofessional Collaboration Interventions for Elderly." International journal of integrated care vol. 16,2 (2016): 5. doi: https://doi.org/10.5334/ijic.2017
Tsakitzidis G, Timmermans O, Callewaert N, Verhoeven V, Lopez-Hartmann M, Truijen S, Meulemans H, Van Royen P. Outcome Indicators on Interprofessional Collaboration Interventions for Elderly. Int J Integr Care. 2016 May 16;16(2):5. doi: 10.5334/ijic.2017. PMID: 27616961; PMCID: PMC5015552.
Copy Download .nbib Format: NLM
Electrocardiographic recording direction impacts ventricular fibrillation waveform measurements: A potential pitfall for VF-waveform guided defibrillation protocols.

Resuscitation plus

Thannhauser J, Nas J, Vart P, Smeets JLRM, de Boer MJ, van Royen N, Bonnes JL, Brouwer MA.
PMID: 34223374
Resusc Plus. 2021 Apr 02;6:100114. doi: 10.1016/j.resplu.2021.100114. eCollection 2021 Jun.

AIM: In cardiac arrest, ventricular fibrillation (VF) waveform analysis has identified the amplitude spectrum area (AMSA) as a key predictor of defibrillation success and favorable neurologic survival. New resuscitation protocols are under investigation, where prompt defibrillation is restricted to...

Cite
Thannhauser J, Nas J, Vart P, et al. Electrocardiographic recording direction impacts ventricular fibrillation waveform measurements: A potential pitfall for VF-waveform guided defibrillation protocols. Resusc Plus. 2021;6:100114doi: 10.1016/j.resplu.2021.100114.
Thannhauser, J., Nas, J., Vart, P., Smeets, J. L. R. M., de Boer, M. J., van Royen, N., Bonnes, J. L., & Brouwer, M. A. (2021). Electrocardiographic recording direction impacts ventricular fibrillation waveform measurements: A potential pitfall for VF-waveform guided defibrillation protocols. Resuscitation plus, 6100114. https://doi.org/10.1016/j.resplu.2021.100114
Thannhauser, Jos, et al. "Electrocardiographic recording direction impacts ventricular fibrillation waveform measurements: A potential pitfall for VF-waveform guided defibrillation protocols." Resuscitation plus vol. 6 (2021): 100114. doi: https://doi.org/10.1016/j.resplu.2021.100114
Thannhauser J, Nas J, Vart P, Smeets JLRM, de Boer MJ, van Royen N, Bonnes JL, Brouwer MA. Electrocardiographic recording direction impacts ventricular fibrillation waveform measurements: A potential pitfall for VF-waveform guided defibrillation protocols. Resusc Plus. 2021 Apr 02;6:100114. doi: 10.1016/j.resplu.2021.100114. eCollection 2021 Jun. PMID: 34223374; PMCID: PMC8244524.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 207 entries